Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francisca Lago

Showing results (141-150 of 150) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 150 results.
Laboratory Investigation; a Journal of Technical Methods and Pathology|April 28, 2022
WISP-2 modulates the induction of inflammatory mediators and cartilage catabolism in chondrocytesClara Ruiz-Fernández, María González-Rodríguez, Vanessa Abella, et al.
Frontiers in Pharmacology|February 21, 2022
The Treatment With the SGLT2 Inhibitor Empagliflozin Modifies the Hepatic Metabolome of Male Zucker Diabetic Fatty Rats Towards a Protective ProfileAlana Aragón-Herrera, Manuel Otero-Santiago, Laura Anido-Varela, et al.
Biochemical Pharmacology|October 25, 2019
Empagliflozin reduces the levels of CD36 and cardiotoxic lipids while improving autophagy in the hearts of Zucker diabetic fatty ratsAlana Aragón-Herrera, Sandra Feijóo-Bandín, Manuel Otero Santiago, et al.
Endocrinology|September 26, 2013
Nesfatin-1 in human and murine cardiomyocytes: synthesis, secretion, and mobilization of GLUT-4Sandra Feijóo-Bandín, Diego Rodríguez-Penas, Vanessa García-Rúa, et al.
The Journal of Physiology|January 13, 2016
Endolysosomal two-pore channels regulate autophagy in cardiomyocytesVanessa García-Rúa, Sandra Feijóo-Bandín, Diego Rodríguez-Penas, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 17, 2023
The lipidomic and inflammatory profiles of visceral and subcutaneous adipose tissues are distinctly regulated by the SGLT2 inhibitor empagliflozin in Zucker diabetic fatty ratsAlana Aragón-Herrera, Sandra Moraña-Fernández, Manuel Otero-Santiago, et al.
International Journal of Molecular Sciences|September 28, 2023
Role of Soluble ST2 Biomarker in Predicting Recurrence of Atrial Fibrillation after Electrical Cardioversion or Pulmonary Vein IsolationJavier García-Seara, Laila González Melchor, Javier Rodríguez García, et al.
Biochemical Pharmacology|October 18, 2024
Cardiometabolic effects of sacubitril/valsartan in a rat model of heart failure with preserved ejection fractionSandra Moraña-Fernández, Xocas Vázquez-Abuín, Alana Aragón-Herrera, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|August 12, 2025
Soluble guanylate cyclase stimulation improves cardiac function and mitochondrial activity in a rat model of early-stage heart failure with preserved ejection fractionXocas Vázquez-Abuín, Sandra Moraña-Fernández, Alana Aragón-Herrera, et al.
European Journal of Clinical Investigation|January 21, 2025
Meteorin-like protein plasma levels are associated with worse outcomes in de novo heart failureLaura Anido-Varela, Alana Aragón-Herrera, Adrián González-Maestro, et al.
Pageof 15

Showing results (141-150 of 150) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 150 results.
Laboratory Investigation; a Journal of Technical Methods and Pathology|April 28, 2022
WISP-2 modulates the induction of inflammatory mediators and cartilage catabolism in chondrocytesClara Ruiz-Fernández, María González-Rodríguez, Vanessa Abella, et al.
Frontiers in Pharmacology|February 21, 2022
The Treatment With the SGLT2 Inhibitor Empagliflozin Modifies the Hepatic Metabolome of Male Zucker Diabetic Fatty Rats Towards a Protective ProfileAlana Aragón-Herrera, Manuel Otero-Santiago, Laura Anido-Varela, et al.
Biochemical Pharmacology|October 25, 2019
Empagliflozin reduces the levels of CD36 and cardiotoxic lipids while improving autophagy in the hearts of Zucker diabetic fatty ratsAlana Aragón-Herrera, Sandra Feijóo-Bandín, Manuel Otero Santiago, et al.
Endocrinology|September 26, 2013
Nesfatin-1 in human and murine cardiomyocytes: synthesis, secretion, and mobilization of GLUT-4Sandra Feijóo-Bandín, Diego Rodríguez-Penas, Vanessa García-Rúa, et al.
The Journal of Physiology|January 13, 2016
Endolysosomal two-pore channels regulate autophagy in cardiomyocytesVanessa García-Rúa, Sandra Feijóo-Bandín, Diego Rodríguez-Penas, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 17, 2023
The lipidomic and inflammatory profiles of visceral and subcutaneous adipose tissues are distinctly regulated by the SGLT2 inhibitor empagliflozin in Zucker diabetic fatty ratsAlana Aragón-Herrera, Sandra Moraña-Fernández, Manuel Otero-Santiago, et al.
International Journal of Molecular Sciences|September 28, 2023
Role of Soluble ST2 Biomarker in Predicting Recurrence of Atrial Fibrillation after Electrical Cardioversion or Pulmonary Vein IsolationJavier García-Seara, Laila González Melchor, Javier Rodríguez García, et al.
Biochemical Pharmacology|October 18, 2024
Cardiometabolic effects of sacubitril/valsartan in a rat model of heart failure with preserved ejection fractionSandra Moraña-Fernández, Xocas Vázquez-Abuín, Alana Aragón-Herrera, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|August 12, 2025
Soluble guanylate cyclase stimulation improves cardiac function and mitochondrial activity in a rat model of early-stage heart failure with preserved ejection fractionXocas Vázquez-Abuín, Sandra Moraña-Fernández, Alana Aragón-Herrera, et al.
European Journal of Clinical Investigation|January 21, 2025
Meteorin-like protein plasma levels are associated with worse outcomes in de novo heart failureLaura Anido-Varela, Alana Aragón-Herrera, Adrián González-Maestro, et al.
Pageof 15